Voyager Therapeutics, Inc.
VYGR
$3.26
-$0.15-4.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -107.73M | -116.64M | -119.72M | -126.78M | -107.93M |
| Total Depreciation and Amortization | 3.82M | 3.98M | 4.06M | 4.02M | 4.22M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.34M | 16.29M | 16.83M | 15.94M | 14.46M |
| Change in Net Operating Assets | -32.01M | -31.62M | -33.63M | -9.91M | -24.40M |
| Cash from Operations | -120.57M | -127.99M | -132.47M | -116.73M | -113.65M |
| Capital Expenditure | -847.00K | -1.95M | -2.60M | -2.13M | -2.18M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 106.65M | 94.30M | 128.04M | 52.94M | 82.46M |
| Cash from Investing | 105.80M | 92.35M | 125.45M | 50.82M | 80.28M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.46M | 4.07M | 816.00K | 1.25M | 1.18M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.46M | 4.07M | 816.00K | 1.25M | 1.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.31M | -31.58M | -6.21M | -64.66M | -32.19M |